What is the best course of action for IPR trolling and the standing question of third parties? District courts sometimes permit third parties to join proceedings. Should the PTAB be different? IPR and CBM proceedings were created expressly to address tech patents rather pharmaceutical patents. Why are we seeing the opposite phenomena? The PTAB is ironically highlighting how undervalued patents have been. Is the secondary market betting for and against PTAB proceedings more profitable than betting on new pharmaceutical compounds or treatments?
How will scientists be incented to solve health and welfare issues in the future? Are new biotech solutions patentable in the US? Will the leading edge the US built in biotech via Chakrabarty migrate elsewhere? Will scientists from around the world come to the United States to experiment, or stay put?
This panel will explore the business models for companies operating in the highly competitive markets for pharmaceuticals, biotech, medical devices, and energy.
Moderator:
Hans Sauer, Deputy General Counsel for Intellectual Property at the Biotechnology Industry Organization and Georgetown University School of Law
Panel:
Carl Gulbrandsen, Managing Director, Wisconsin Alumni Research Foundation
Michael Locascio, Manager of Intellectual Property Strategy, Catalysts, BASF
Craig Smith, Development and Commercialization Professional, Sandia National Laboratories
Paul A. Stone, General Counsel, Chief Operating Officer, 5AM Ventures
Roy Waldron, SVP and Associate General Counsel, Chief IP Counsel, Pfizer
If you intend to take a course for CLE credit, please make sure your state is listed in the "Accreditation" section to the upper right of the program description. Accreditation displayed is unique to the purchased program format (live conference, live webcast, on demand, podcast). Credit totals listed for live conferences are the maximum credits available. Credits issued will be based upon actual time in attendance. Credit totals for other formats are for complete programs. Partial credit is not available for any online or downloadable format.
West LegalEdcenter will not provide accreditation for states not listed.
This product is intended for individual use by the named purchaser. Group viewings for online programs may be arranged for five or more attorneys within the same organization prior to viewing by emailing west.wlec-sales@thomson.com.